Cantitate/Preț
Produs

Immunotherapy for Gastrointestinal Cancer

Editat de David Kerr, Rebecca Johnson
en Limba Engleză Hardback – 16 ian 2017
This book is about the manipulation of the immune system as a therapeutic approach to gastrointestinal cancer and its clinical applications, exploring therapeutic approaches which might be taken under the broad banner of immunotherapy.
Starting by introducing concepts of modern immunology, the clinical applications of immunotherapy are then discussed. The reader will learn about the three broad classes of immune therapeutic agents: cell-based treatment; antibody therapy; cytokine application and the key effector cells and mechanisms which might cause tumour rejection.  The reverse side of this equation, the genetic and molecular mechanisms which the tumour can use to escape immune control and regulation, is also discussed.  Through reviewing the most up-to-date evidence, this volume provides an overview of the important scientific lessons learned from past failure of immunotherapeutics in the clinic and highlights more positive recent data, coupled to practical guidelines for clinical usage.
Written by a team of worldwide experts, this is an indispensable guide for medical oncologists, surgical oncologists, radiation therapists, pharmacists, oncology nurse specialists.  
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 64524 lei  39-44 zile
  Springer International Publishing – 12 iul 2018 64524 lei  39-44 zile
Hardback (1) 101887 lei  3-5 săpt.
  Springer International Publishing – 16 ian 2017 101887 lei  3-5 săpt.

Preț: 101887 lei

Preț vechi: 107249 lei
-5% Nou

Puncte Express: 1528

Preț estimativ în valută:
19505 20275$ 16172£

Carte disponibilă

Livrare economică 16-30 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319430614
ISBN-10: 3319430610
Pagini: 256
Ilustrații: VIII, 252 p. 23 illus. in color.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.64 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

Introduction to modern immunology.- Cell based therapy – modified cancer cells.- Vaccines for GI cancer.-  Antibody delivery of radioactive ‘warheads’ and cytotoxins.- Antibodies which inhibit specific cell pathways.- PD1 and PD1l immune checkpoint inhibitors.- The Role of the JAK/STAT Signaling Pathway in Immunoregulation of Gastrointestinal Cancers.- Hyper mutated colorectal cancer and neoantigen load.- Antibodies which inhibit specific cell pathways,  colorectal  cancer.

Notă biografică

David J Kerr CBE MD DSc FRCP(Glas,Lon,Edin) FRCGP FMedSci is Professor of Cancer Medicine, University of Oxford, Adjunct Professor of Medicine, Weill-Cornell College of Medicine and Honorary Professor, University of Xiamen and 2nd Military University, Shanghai. He has a long standing interest in the biology and treatment of colorectal cancer and has contributed many publications to this field. He is former President of the European Society of Medical Oncology and is currently Editor in Chief of the Journal of Global Oncology.
Dr Rebecca Johnson is a junior doctor working at Oxford University Hospitals NHS Foundation Trust.  Rebecca holds a Bachelor of Science degree in Genetics and a PhD in DNA double strand break repair. Rebecca was awarded the Irvington Fellowship of the Cancer Research Institute of the United States of America, for work investigating the initiating molecular lesions of common malignancies, this award was tenured at New York University. Following this postdoctoral fellowship, she studied medicine at the University of Birmingham and has recently entered the Core Medical training programme.

Textul de pe ultima copertă

This book is about the manipulation of the immune system as a therapeutic approach to gastrointestinal cancer and its clinical applications, exploring therapeutic approaches which might be taken under the broad banner of immunotherapy.
Starting by introducing concepts of modern immunology, the clinical applications of immunotherapy are then discussed. The reader will learn about the three broad classes of immune therapeutic agents: cell-based treatment; antibody therapy; cytokine application and the key effector cells and mechanisms which might cause tumour rejection.  The reverse side of this equation, the genetic and molecular mechanisms which the tumour can use to escape immune control and regulation, is also discussed.  Through reviewing the most up-to-date evidence, this volume provides an overview of the important scientific lessons learned from past failure of immunotherapeutics in the clinic and highlights more positive recent data, coupled to practical guidelines for clinical usage. Written by a team of worldwide experts, this is an indispensable guide for medical oncologists, surgical oncologists, radiation therapists, pharmacists, oncology nurse specialists.  

Caracteristici

Explores recent advances in cancer immunotherapy and their application in clinical practice Introduces concepts of modern immunology to the oncology expert Reviews the evidence and scientific lessons learnt from use of immunotherapeutics in the clinic Provides practical guidelines for clinical usage